{"id":531904,"date":"2021-02-25T18:38:01","date_gmt":"2021-02-25T18:38:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=531904"},"modified":"2021-02-25T18:38:01","modified_gmt":"2021-02-25T18:38:01","slug":"psoriasis-pipeline-clinical-trials-and-emerging-therapy-assessment-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/psoriasis-pipeline-clinical-trials-and-emerging-therapy-assessment-by-delveinsight_531904.html","title":{"rendered":"Psoriasis Pipeline, Clinical Trials and Emerging Therapy Assessment by DelveInsight"},"content":{"rendered":"
\"Psoriasis<\/a><\/div>\n

DelveInsight has launched a new report on Psoriasis Pipeline<\/strong><\/a><\/p>\n

 <\/p>\n

Psoriasis is a chronic, immune mediated inflammatory skin disease characterized by the presence of papules and plaques occurring most commonly on the elbows, knees, scalp, and lower back, but is not limited to these areas.<\/p>\n

 <\/p>\n

Request for free sample copy- https:\/\/www.delveinsight.com\/sample-request\/psoriasis-pipeline-insight <\/a><\/strong><\/p>\n

 <\/p>\n

Psoriasis Pipeline<\/strong> analysis across different stages of development (Phase III and Phase II), different emerging trendsand comparative analysis of Psoriasis Pipeline<\/strong> products with detailed clinical profiles, key cross -competition, launch date along with product development activities.<\/p>\n

 <\/p>\n

Psoriasis Pipeline <\/strong><\/p>\n

The available therapeutics treatment options in Psoriasis Landscape aim to modulate gene transcription, inhibit cell proliferation and promote keratinocyte differentiation.<\/p>\n

 <\/p>\n

Psoriasis Treatment<\/strong><\/p>\n

Although there is no cure for psoriasis, there are multiple effective treatment options and topical therapy is the standard of care for treatment. Mild to moderate psoriasis can be treated topically with a combination of glucocorticoids, vitamin D analogues, and phototherapy. Systemic treatment is required in moderate to severe cases. Despite its considerable effect on quality of life, psoriasis is underdiagnosed and undertreated. Better understanding of the disease and increase in available treatment options will aid in optimal management and improve patient outcomes in coming years.<\/p>\n

 <\/p>\n

Marketed drugs included in the report<\/strong><\/p>\n